The low FODMAP diet in anxiety, depression and quality of life in irritable bowel syndrome by Rome IV criteria

  • Davi Renan Souto Torres Discente do Curso de Graduação em Nutrição na Universidade Estadual do Ceará (UECE), Fortaleza-CE, Brasil.
  • Ienara David Sombra de Lima Discente do Curso de Graduação em Nutrição na Universidade Estadual do Ceará (UECE), Fortaleza-CE, Brasil.
  • Ruth Silva Galdino Discente do Curso de Graduação em Nutrição na Universidade Estadual do Ceará (UECE), Fortaleza-CE, Brasil.
  • Victor Vincent Morais de Lima Discente do Curso de Graduação em Nutrição na Universidade Estadual do Ceará (UECE), Fortaleza-CE, Brasil.
  • Pedro dos Santos Carlos Discente do Curso de Graduação em Nutrição na Universidade Estadual do Ceará (UECE), Fortaleza-CE, Brasil.
  • Larissa Luna Queiroz Docente do Curso de Nutrição na Universidade Estadual do Ceará (UECE), Fortaleza-CE, Brasil.
Keywords: Irritable Bowel Syndrome, FODMAP, Anxiety, Depression, Quality of life

Abstract

Introduction: Irritable bowel syndrome is one of the main gastrointestinal disorders, with a significant impact on physical and mental well-being. Few studies address the effects of the low FODMAP diet on anxiety, depression, and quality of life, especially with the current diagnostic criteria, Rome IV. Objective: To evaluate the effects of the low FODMAP diet on anxiety, depression, and quality of life using the Rome IV criteria in IBS patients. Materials and methods: This is an integrative review. The search was carried out between April and June 2023 in four databases: PubMed, Cochrane Library, Virtual Health Library, and Scopus. The PICOS criteria was used for the construction of the guiding question, and the PRISMA-ScR for the selection of articles. Results and discussion: Four studies were selected, with the intervention of a low FODMAP diet, evaluating psychological (HADS) and gastrointestinal symptoms (IBS-SSS), and quality of life (IBS-QOL). Dietary, psychological, and gastrointestinal factors are directly associated with quality of life. Conclusion: The interaction between the brain-gut-microbiota axis has a significant impact on IBS symptoms, including changes in bowel habits, abdominal pain, and psychiatric comorbidities. These alterations may explain the high prevalence of anxiety, depression, and a lower quality of life in IBS patients. The low FODMAP diet was found to be superior in reducing gastrointestinal and psychological symptoms and improving quality of life. The adherence and acceptability of the low FODMAP diet are important considerations when evaluating its clinical application.

References

-Aziz, I.; Tornblom, H.; Palsson, O.S.; Whitehead, W.E.; Simrén, M. How the Change in IBS Criteria from Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors. The American Journal of Gastroenterology. Vol. 113. Num. 7. 2018. p. 1017-1025.

-Bellini, M.; Tonarelli, S.; Nagy, A.G.; Pacnetti, A.; Costa, F.; Ricchiuti, A.; Bortoli, N.; Mosca, M.; Marchi, S.; Rossi, A. Low FODMAP Diet: Evidence, Doubts, and Hopes, Nutrients. Vol. 12. Num. 1. 2020. p. 148.

-Black, C.J.; Ford, A.C. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nature Reviews. Gastroenterology & Hepatology. Vol. 17. Num. 8. 2020. p. 473-486.

-Chey, W.D; Keefer, L.; Whelan, K.; Gibson, P.R. Behavioral and Diet Therapies in Integrated Care for Patients with Irritable Bowel Syndrome. Gastroenterology. Vol. 160. Num. 1. 2021. p. 47-62.

-Colomier, E.; Oudenhove, L.V.; Tack, J.; Bohn, L.; Bennet, S.; Nybacka, S.; Storsrud, S.; Ohman, L.; Tornblom, H.; Simrén, M. Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome. Nutrients. Vol. 14, Num. 397. 2022. p. 397.

-Goodoory, V.C.; Houghton, L.A.; Yiannakoyu, Y.; Black, C.J.; Ford, A.C. Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study. Clinical Gastroenterology and Hepatology. Vol. 20. Num. 3. 2022. p. 569-577.

-Goyal, O.; Batta, S.; Nohria, S.; Kishore, H.; Goyal, P.; Sehgal, R.; Sood, A. Low fermentable, oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: A prospective, randomized trial. Journal of Gastroenterology and Hepatology. Vol. 38. Num. 8. 2021. p. 2107-2115.

-Guerreiro, M.M.; Santos, Z.; Carolino. E.; Correa, J.; Cravo, M.; Augusto, F.; Chagas, C.; Guerreiro, C.S. Effectiveness of Two Dietary Approaches on the Quality of Life and Gastrointestinal Symptoms of Individuals with Irritable Bowel Syndrome. Journal of Clinical Medicine. Vol. 9. Num.1. 2020. p.125.

-Hayes, P.; Corish, C.; O'Mahony, E.; Quigley, E.M.M. A dietary survey of patients with irritable bowel syndrome. Journal of Human Nutrition and Dietetics. Vol 27. Num. 2. 2014. p. 36-47.

-Hill, P.; Muir, J.G.; Gibson, P.R. Controversies and Recent Developments of the Low-FODMAP Diet. Gastroenterology & Hepatology. Vol. 13. Num. 1. 2017. p. 36-4

-Lacy, B.E.; Pimentel, M.; Brenner, D.M.; Chey, W.D.; Keefer, L.A.; Long, M.D.; Moshiree, B. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology. Vol. 116. Num. 1. 2021. p. 17-44.

-Margolis, K.G.; Cryan, J.F.; Mayer, E.A. The Microbiota-Gut-Brain Axis: From Motility to Mood. Gastroenterology. Vol. 160. Num. 5. 2021. p. 1486-1501.

-Mayer, E.A.; Ryu, H.J.; Bhatt, R.R. The neurobiology of irritable bowel syndrome. Molecular Psychiatry. Vol. 28. Num. 4. 2023. p. 1451-65.

-Melchior, C.; Colomier, E.; Trindade, I. A.; Khadija, M.; Hreinsson, J.P.; Tornblom, H.; Simrén, M. Irritable bowel syndrome: Factors of importance for disease-specific quality of life. United European Gastroenterology. Vol. 10. Num 7. 2022. p. 754-764.

-Paduano, D.; Cingolani, A.; Tanda, E.; Usai, P. Effect of Three Diets (Low-FODMAP, Gluten-free and Balanced) on Irritable Bowel Syndrome Symptoms and Health-Related Quality of Life. Nutrients. Vol. 11. Num. 7. 2019. p. 1566.

-Palsson, O.S.; Whitehead, W.E; Tilburg, M.A.L.; Chang, L.; Chey, W.; Crowell, M.D.; Keefer, L.; Lembo, A.J.; Parkman, H.P.; Rao, S.S.C.; Sperber, A.; Spiegel, B.; Tack, J.; Vanner, S.; Walker, L.S.; Whorwell, P.; Yang, Yunsheng. Development and Validation of the Rome IV Diagnostic Questionnaire for Adults. Gastroenterology. Vol. 150. Num. 6. 2016. p. 1481-1491.

-Rej, A.; Avery, A.; Aziz, I.; Black, C.J.; Bowyer, R.K.; Buckle, R.L.; Seamark, L.; Shaw, C.C.; Thompson, J.; Trott, N.; Williams, M.; Sanders, D.S. Diet and irritable bowel syndrome: an update from a UK consensus meeting. BMC Medicine. Vol. 20. Num. 287. 2022a. p. 287.

-Rej, A.; Sanders, D.S.; Shaw, C.C.; Buckle, R.; Trott, N.; Agrawal, A.; Aziz, I. Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the low FODMAP Diet, and the Gluten-Free Diet. Clinical Gastroenterology and Hepatology. Vol. 20. Num. 12. 2022b. p. 2876-2887.

-Sperber, A.D; Bangdiwala, S.I.; Drossman, D.A.; Ghoshal, U.C.; Simrén, M.; Tack, J.; Whitehead W.E.; Dumitrascu, D.L.; Fang, X.; Fukudo, S.; Kellow, J.; Okeke, E.; Quigley, E.M.M.; Schmulson, M.; Whorwell P.; Archampong, T.; Adibi, P.; Andresen, V.; Benninga M.A.; Bonaz, B.; Bor, S.; Fenrnadez, L.B.; Choi, S.C.; Corazziari, E.S.; Francisconi, C.; Hani, A.; Lazebnik, L.; Lee, Y.Y.; Mulak, A.; Rahman, M. M.; Santos, J.; Setshedi, M; Syam, A.F.; Vanner, S.; Wong, R.K.; Lopez-Colombo, A.; Costa, V.; Dickman, R.; Kanazawa, M.; Keshteli, A.H.; Khatun, R.; Maleki, I.; Poitras, P.; Pratap, N.; Stefanyuk, O.; Thomson. S; Zeevenhooven, J.; Palsson, O.S. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. Vol. 160. Num. 1. 2021. p. 99-114.

-Staudacher, H.M.; Gibson, P.R. Traditional Dietary Advice, Low FODMAP Diet, or Gluten-Free Diet for IBS: Growing Understanding but Incertainties Remain. Clinical Gastroenterology and Hepatology. Vol. 21. Num. 4. 2023. p. 1119-1120.

-Staudacher, H.M.; Ralph, F.S.E.; Irving, P.M.; Whelan, K.; Lomer, M.C.E. Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet. Journal of the Academy of Nutrition and Dietetics. Vol. 120. Num. 4. 2020. p. 535-547.

-Sundas, A.; Sampath, H.; Lamtha, S.C.; Soohinda, G.; Dutta, S. Psychosocial quality-of-life correlates in functional gastrointestinal disorders. Revista de Gastroenterologia de Mexico. 2022.

-Tarar, Z. I.; Farooq, U.; Zafar, Y.; Gandhi, M.; Raza, S.; Kamal, F.; Tarar, M.F.; Ghouri, Y.A. Burden of anxiety and depression among hospitalized patients with irritable bowel syndrome: a nationwide analysis. Irish Journal of Medical Science. 2023.

-Vork, L.; Weerts, Z.Z.R.M.; Mujagic, Z.; Kruimel, J.W.; Hesselink, M.A.M.; Muris, J.W.M.; Keszthelyi, D.; Jonkers, D.M.A.E.; Masclee, A.A.M. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study. Neurogastroenterology and Motility. Vol. 30. Num. 2. 2018.

Published
2024-06-20
How to Cite
Torres, D. R. S., Lima, I. D. S. de, Galdino, R. S., Lima, V. V. M. de, Carlos, P. dos S., & Queiroz, L. L. (2024). The low FODMAP diet in anxiety, depression and quality of life in irritable bowel syndrome by Rome IV criteria. Brazilian Journal of Obesity, Nutrition and Weight Loss, 18(114), 509-516. Retrieved from https://www.rbone.com.br/index.php/rbone/article/view/2425
Section
Scientific Articles - Original